300 related articles for article (PubMed ID: 10861276)
21. A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection.
Frelin L; Wahlström T; Tucker AE; Jones J; Hughes J; Lee BO; Billaud JN; Peters C; Whitacre D; Peterson D; Milich DR
J Virol; 2009 Feb; 83(3):1379-92. PubMed ID: 19004949
[TBL] [Abstract][Full Text] [Related]
22. Tapasin modification on the intracellular epitope HBcAg18-27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo.
Chen X; Tang Y; Zhang Y; Zhuo M; Tang Z; Yu Y; Zang G
Lab Invest; 2014 May; 94(5):478-90. PubMed ID: 24614195
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
[TBL] [Abstract][Full Text] [Related]
24. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.
Rehermann B; Fowler P; Sidney J; Person J; Redeker A; Brown M; Moss B; Sette A; Chisari FV
J Exp Med; 1995 Mar; 181(3):1047-58. PubMed ID: 7532675
[TBL] [Abstract][Full Text] [Related]
25. A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients.
Sing GK; Ladhams A; Arnold S; Parmar H; Chen X; Cooper J; Butterworth L; Stuart K; D'Arcy D; Cooksley WG
J Viral Hepat; 2001 Jan; 8(1):19-29. PubMed ID: 11155148
[TBL] [Abstract][Full Text] [Related]
26. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.
Jung MC; Diepolder HM; Spengler U; Wierenga EA; Zachoval R; Hoffmann RM; Eichenlaub D; Frösner G; Will H; Pape GR
J Virol; 1995 Jun; 69(6):3358-68. PubMed ID: 7538172
[TBL] [Abstract][Full Text] [Related]
27. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice.
Zhang Y; Li S; Shan M; Pan X; Zhuang K; He L; Gould K; Tien P
Immunology; 2007 May; 121(1):105-12. PubMed ID: 17244158
[TBL] [Abstract][Full Text] [Related]
29. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
Xiang Y; Chen P; Xia JR; Zhang LP
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
[TBL] [Abstract][Full Text] [Related]
30. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen.
Bertoletti A; Ferrari C; Fiaccadori F; Penna A; Margolskee R; Schlicht HJ; Fowler P; Guilhot S; Chisari FV
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10445-9. PubMed ID: 1660137
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. Evidence that antibody modulation may cause protracted infection.
Pignatelli M; Waters J; Lever A; Iwarson S; Gerety R; Thomas HC
J Hepatol; 1987 Feb; 4(1):15-21. PubMed ID: 3494760
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
[TBL] [Abstract][Full Text] [Related]
33. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals.
Hashimoto M; Kitano M; Honda K; Koizumi H; Dohki S; Oka S; Takiguchi M
Hum Immunol; 2010 Feb; 71(2):123-7. PubMed ID: 19891998
[TBL] [Abstract][Full Text] [Related]
34. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants.
Löhr HF; Weber W; Schlaak J; Goergen B; Meyer zum Buschenfelde KH; Gerken G
Hepatology; 1995 Jul; 22(1):61-8. PubMed ID: 7601434
[TBL] [Abstract][Full Text] [Related]
35. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN
J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429
[TBL] [Abstract][Full Text] [Related]
36. Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B.
Ciftci S; Keskin F; Abaci N; Akyuz F; Cakiris A; Badur S; Kaymakoglu S; Ustek D
Clin Lab; 2018 Mar; 64(3):303-310. PubMed ID: 29739114
[TBL] [Abstract][Full Text] [Related]
37. [Detection of HBcAg-specific cytotoxic lymphocytes and their association with clinical status in patients with hepatitis B].
Fan ZP; Wang FS; Xu DP; Chu FL; Shi M; Zhou Y; Zhang LX
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2073-6. PubMed ID: 15730619
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
[TBL] [Abstract][Full Text] [Related]
39. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
Vertuani S; Bazzaro M; Gualandi G; Micheletti F; Marastoni M; Fortini C; Canella A; Marino M; Tomatis R; Traniello S; Gavioli R
Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
[TBL] [Abstract][Full Text] [Related]
40. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
